Correlation between albuminuria and interstitial injury marker reductions associated with SGLT2 inhibitor treatment in diabetic patients with renal dysfunction

BACKGROUND: We investigated the effects of sodium–glucose cotransporter 2 inhibitor (SGLT2i) administration focusing on its involvement in tubulo-interstitial disorders in diabetic kidney. METHODS: Enrolled patients with diabetic kidney disease received a mean dose of 52.3 mg of an SGLT2i (ipraglifl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Saeko, Takayanagi, Kaori, Shimizu, Taisuke, Kanozawa, Koichi, Iwashita, Takatsugu, Hasegawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356509/
https://www.ncbi.nlm.nih.gov/pubmed/35933386
http://dx.doi.org/10.1186/s40001-022-00737-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356509/
https://www.ncbi.nlm.nih.gov/pubmed/35933386
http://dx.doi.org/10.1186/s40001-022-00737-5

Ejemplares similares